glp 1 and pancreatic cancer 🩺 Could Weight Loss Drugs Be a Secret Weapon Against Cancer? Could Weight Loss Drugs Be a Secret Weapon Against Cancer? 💡 Why it matters: This shifts the narrative of GLP-1s from Evaluating the Rates of Pancreatitis

The SELECT trial establishing semaglutides 20% reduction in major adverse cardiovascular events has converted GLP-1 receptor agonists from single-indication obesity drugs into foundational chronic disease therapeutics demanding continuous prescription renewal

McLean BD, Buttifant D, Gore CJ, et al

The vial presentation was tidy and the order matched exactly what I selected

I keep an eye on this space because, despite considerable issues with nausea, vomiting, muscle loss, and even rare cases of sudden blindness, the GLP-1 RA drugs may offer the first real hope for patients with metabolic syndrome associated with chronic ulcers

You can then ease back into a typical, healthy eating pattern.